Literature DB >> 26421071

Popliteal Retrograde Approach is Effective and Safe for Superficial Femoral Artery Chronic Total Occlusion.

Daisuke Ueshima1, Takashi Ashikaga1, Tsukasa Shimura2, Yu Hatano1, Taro Sasaoka1, Ken Kurihara3, Shunji Yoshikawa1, Yasuhiro Maejima1, Mitsuaki Isobe1.   

Abstract

OBJECTIVE: Endovascular treatment (EVT) using a popliteal approach is effective for superficial femoral artery (SFA) chronic total occlusion (CTO); however, its effectiveness, safety, and consequent complications are unclear.
MATERIALS AND METHODS: We studied 324 consecutive EVTs (in 187 patients) performed at three centers between April 2008 and March 2013, and selected all EVTs that included SFA CTO regions. A total of 91 EVTs (in 65 patients) were included and divided into two groups; "with popliteal approach" (WPA) and "without popliteal approach" (WOPA).
RESULTS: Despite higher rates of hypertension (WPA, 88.9% vs. WOPA, 69.1%; p = 0.04) and CTO length >200 mm (55.6% vs. 28.3%, respectively; p <0.01), the primary success rate was better in the WPA group (97.2% vs. 78.2%, respectively; p <0.01); however, both total complication rate and major complication rate were not significantly different. We compared popliteal puncture using a sheath and using a microcatheter alone. There were no significant differences between sheath and microcatheter use in terms of primary success rates (95.5% vs. 100%, respectively; p = 0.61) and puncture site complications (22.7% vs. 14.2%, respectively; p = 0.53).
CONCLUSION: A popliteal approach improved the primary success rate of EVT for SFA CTO.

Entities:  

Keywords:  endovascular treatment; popliteal puncture; retrograde approach; superficial femoral artery total occlusion

Year:  2015        PMID: 26421071      PMCID: PMC4575334          DOI: 10.3400/avd.oa.15-00025

Source DB:  PubMed          Journal:  Ann Vasc Dis        ISSN: 1881-641X


  20 in total

1.  Excimer laser-assisted recanalization of long, chronic superficial femoral artery occlusions.

Authors:  D Scheinert; J R Laird; M Schröder; H Steinkamp; J O Balzer; G Biamino
Journal:  J Endovasc Ther       Date:  2001-04       Impact factor: 3.487

2.  Five-year retrograde transpopliteal angioplasty results compared with antegrade angioplasty.

Authors:  C Evans; N Peter; M Gibson; E Ph Torrie; R B Galland; T R Magee
Journal:  Ann R Coll Surg Engl       Date:  2010-05       Impact factor: 1.891

3.  Efficiency, safety, and long-term follow-up of retrograde approach for CTO recanalization: initial (Belgrade) experience with international proctorship.

Authors:  Sinisa Stojkovic; George Sianos; Osamu Katoh; Alfredo R Galassi; Branko Beleslin; Vladan Vukcevic; Milan Nedeljkovic; Goran Stankovic; Dejan Orlic; Milan Dobric; Miloje Tomasevic; Miodrag Ostojic
Journal:  J Interv Cardiol       Date:  2012-08-16       Impact factor: 2.279

4.  A sheathless retrograde approach via the popliteal artery is useful and safe for treating chronic total occlusions in the superficial femoral artery.

Authors:  Takahiro Tokuda; Keisuke Hirano; Toshiya Muramatsu; Reiko Tsukahara; Masatsugu Nakano
Journal:  J Endovasc Ther       Date:  2014-04       Impact factor: 3.487

5.  Retrograde popliteal access in the supine patient for recanalization of the superficial femoral artery: initial results.

Authors:  Fabrizio Fanelli; Pierleone Lucatelli; Massimiliano Allegritti; Mario Corona; Plinio Rossi; Roberto Passariello
Journal:  J Endovasc Ther       Date:  2011-08       Impact factor: 3.487

6.  Percutaneous transluminal angioplasty in femoral artery occlusions: primary and long-term results in 107 claudicant patients using femoral and popliteal catheterization techniques.

Authors:  P J Matsi; H I Manninen; H K Söder; P Mustonen; J Kouri
Journal:  Clin Radiol       Date:  1995-04       Impact factor: 2.350

7.  Non-randomized, prospective, multi-centre evaluation of the ABSOLUTE .035 peripheral self-expanding stent system for occluded or stenotic superficial femoral or proximal popliteal arteries (ASSESS Trial): acute and 30-day results.

Authors:  T Zeller; N Saratzis; D Scheinert; E Minar; J P Beregi; M Schillinger; H A Hausegger; M Amor; P Quaretti; R Moratto; C Dorange; E Boone; H Krankenberg
Journal:  J Cardiovasc Surg (Torino)       Date:  2007-12       Impact factor: 1.888

8.  Initial and 3-year results after subintimal versus intraluminal approach for long femoropopliteal occlusion treated with a self-expandable nitinol stent.

Authors:  Yoshimitsu Soga; Osamu Iida; Kenji Suzuki; Keisuke Hirano; Daizo Kawasaki; Yoshiaki Shintani; Nobuhiro Suematsu; Terutoshi Yamaoka
Journal:  J Vasc Surg       Date:  2013-08-01       Impact factor: 4.268

9.  Statin therapy improves cardiovascular outcome of patients with peripheral artery disease.

Authors:  Martin Schillinger; Markus Exner; Wolfgang Mlekusch; Jasmin Amighi; Schila Sabeti; Marcus Muellner; Helmut Rumpold; Oswald Wagner; Erich Minar
Journal:  Eur Heart J       Date:  2004-05       Impact factor: 29.983

Review 10.  Peripheral artery disease: potential role of ACE-inhibitor therapy.

Authors:  Giuseppe Coppola; Giuseppe Romano; Egle Corrado; Rosa Maria Grisanti; Salvatore Novo
Journal:  Vasc Health Risk Manag       Date:  2008
View more
  3 in total

1.  Retrograde Use of Frontrunner Catheter in Superficial Femoral Artery for Flushing Long Segment Occlusions Involving Distal Common Femoral Artery.

Authors:  Nelson Chavarria; Tae-Hoon Kim; Michael Azrin; Juyong Lee
Journal:  Ann Vasc Dis       Date:  2017-03-31

2.  Twelve months follow-up after retrograde recanalization of superficial femoral artery chronic total occlusion.

Authors:  Joanna Wojtasik-Bakalarz; Salech Arif; Michał Chyrchel; Tomasz Rakowski; Krzysztof Bartuś; Dariusz Dudek; Stanisław Bartuś
Journal:  Postepy Kardiol Interwencyjnej       Date:  2017-03-10       Impact factor: 1.426

3.  Integrated application of antegrade and retrograde recanalization for femoral-popliteal artery chronic total occlusions: outcomes compared with antegrade recanalization.

Authors:  Li-Ming Wei; Yue-Qi Zhu; Pei-Lei Zhang; Hai-Tao Lu; Jun-Gong Zhao
Journal:  Quant Imaging Med Surg       Date:  2018-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.